{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:32Z","timestamp":1793367152250,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["81773341"],"award-info":[{"award-number":["81773341"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.lfs.2020.117443","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:31:56Z","timestamp":1582054316000},"page":"117443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":569,"special_numbering":"C","title":["The mechanisms of lysophosphatidylcholine in the development of diseases"],"prefix":"10.1016","volume":"247","author":[{"given":"Panpan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117443_bb0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","article-title":"Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium","volume":"13","author":"Zhou","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2020.117443_bb0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1126\/science.1061781","article-title":"Xu, Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A","volume":"293","author":"Kabarowski","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117443_bb0015","doi-asserted-by":"crossref","unstructured":"Zhou, X.; Wang, R.; Zhang, T.; Liu, F.; Zhang, W.; Wang, G.; Gu, G.; Han, Q.; Xu, D.; Yao, C., et al. Identification of lysophosphatidylcholines and sphingolipids as potential biomarkers for acute aortic dissection via serum metabolomics. Eur J Vasc Endovasc Surg 2019, 57, 434\u2013441, doi:https:\/\/doi.org\/10.1016\/j.ejvs.2018.07.004.","DOI":"10.1016\/j.ejvs.2018.07.004"},{"key":"10.1016\/j.lfs.2020.117443_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00011-012-0434-x","article-title":"Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine","volume":"61","author":"Hung","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0025","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.atherosclerosis.2007.02.012","article-title":"Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment","volume":"196","author":"Iwase","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2017.10.012","article-title":"Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy","volume":"122","author":"Huffnagel","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.lfs.2020.117443_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2019.04.059","article-title":"Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy","volume":"495","author":"Natarajan","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2020.117443_bb0040","first-page":"115","article-title":"Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy","volume":"12","author":"Wu","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.lfs.2020.117443_bb0045","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1007\/s13277-015-4164-x","article-title":"Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study","volume":"37","author":"Yin","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10753-016-0500-6","article-title":"Alteration of lysophosphatidylcholine-related metabolic parameters in the plasma of mice with experimental Sepsis","volume":"40","author":"Ahn","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2020.117443_bb0055","first-page":"31","article-title":"Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis","volume":"2012","author":"Cho","year":"1805","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117443_bb0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3892\/ol.2014.2214","article-title":"Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer","volume":"8","author":"Kim","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2020.117443_bb0065","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1200\/JCO.2006.08.5571","article-title":"Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer","volume":"25","author":"Zhao","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.117443_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-016-0552-3","article-title":"Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study","volume":"14","author":"Kuhn","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0075","first-page":"65","article-title":"greasing the cholesterol transport machinery","volume":"8","author":"Lagace","year":"2015","journal-title":"Lipid Insights"},{"key":"10.1016\/j.lfs.2020.117443_bb0080","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/1873-3468.12919","article-title":"From yeast to humans - roles of the Kennedy pathway for phosphatidylcholine synthesis","volume":"592","author":"McMaster","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2020.117443_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/STROKEAHA.107.503193","article-title":"Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques","volume":"39","author":"Mannheim","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.lfs.2020.117443_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1742-4658.2008.06771.x","article-title":"The identification of a phospholipase B precursor in human neutrophils","volume":"276","author":"Xu","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2020.117443_bb0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lfs.2018.12.040","article-title":"The role of lysophosphatidic acid in the physiology and pathology of the skin","volume":"220","author":"Lei","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2012.07.038","article-title":"Acyl chain-dependent effect of lysophosphatidylcholine on cyclooxygenase (COX)-2 expression in endothelial cells","volume":"224","author":"Brkic","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1073\/pnas.2536801100","article-title":"T cell chemotaxis to lysophosphatidylcholine through the G2A receptor","volume":"101","author":"Radu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.117443_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076233","article-title":"Lysophosphatidylcholine triggers TLR2- and TLR4-mediated signaling pathways but counteracts LPS-induced NO synthesis in peritoneal macrophages by inhibiting NF-kappaB translocation and MAPK\/ERK phosphorylation","volume":"8","author":"Carneiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117443_bb0115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/656477","article-title":"Schistosomal-derived lysophosphatidylcholine are involved in eosinophil activation and recruitment through Toll-like receptor-2-dependent mechanisms","volume":"202","author":"Magalhaes","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117443_bb0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ejps.2011.10.007","article-title":"Lysophosphatidylcholine induces Ca(2+) mobilization in Jurkat human T lymphocytes and CTLL-2 mouse T lymphocytes by different pathways","volume":"44","author":"Wang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2017.05.145","article-title":"Lysophosphatidylcholine elicits intracellular calcium signaling in a GPR55-dependent manner","volume":"489","author":"Drzazga","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117443_bb0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2006-0391OC","article-title":"Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel","volume":"36","author":"Zhu","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0135","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.lfs.2006.11.017","article-title":"Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells","volume":"80","author":"Li","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbrc.2017.02.087","article-title":"TRPM2 contributes to LPC-induced intracellular Ca(2+) influx and microglial activation","volume":"485","author":"Jeong","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117443_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.RES.81.3.387","article-title":"Lysophosphatidylcholine modulates cardiac I(Na) via multiple protein kinase pathways","volume":"81","author":"Watson","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.RES.80.1.95","article-title":"Na(+)-H+ exchange inhibition protects against mechanical, ultrastructural, and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts","volume":"80","author":"Hoque","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2010.10.006","article-title":"Lysophosphatidylcholine enhances I(Ks) currents in cardiac myocytes through activation of G protein, PKC and Rho signaling pathways","volume":"50","author":"Ding","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2020.117443_bb0160","first-page":"153","article-title":"Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression through reactive oxygen species generation and ERK1\/2 activation in 3T3-L1 adipocytes","volume":"2011","author":"Kuniyasu","year":"1811","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.117443_bb0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.imbio.2010.06.010","article-title":"Sodium dependence of lysophosphatidylcholine-induced caspase-1 activity and reactive oxygen species generation","volume":"216","author":"Schilling","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.lfs.2020.117443_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellimm.2010.08.003","article-title":"Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation","volume":"265","author":"Schilling","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/CVI.00420-09","article-title":"Single lysophosphatidylcholine components exhibit adjuvant activities in vitro and in vivo","volume":"17","author":"Bach","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0029-1186197","article-title":"Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium\/mitocondrion\/caspases-dependent pathway","volume":"76","author":"Song","year":"2010","journal-title":"Planta Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1472-6882-14-233","article-title":"an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbalip.2008.09.007","article-title":"Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand","volume":"1791","author":"Sun","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.117443_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2019.02.038","article-title":"Stearoyl lysophosphatidylcholine inhibits LPS-induced extracellular release of HMGB1 through the G2A\/calcium\/CaMKKbeta\/AMPK pathway","volume":"852","author":"Quan","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0200","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.intimp.2015.07.010","article-title":"Stearoyl lysophosphatidylcholine prevents lipopolysaccharide-induced extracellular release of high mobility group box-1 through AMP-activated protein kinase activation","volume":"28","author":"Kim","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0205","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1073\/pnas.79.10.3285","article-title":"Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine","volume":"79","author":"Hoffman","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.117443_bb0210","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.imbio.2012.10.009","article-title":"Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells","volume":"218","author":"Rolin","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.lfs.2020.117443_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11239-007-0158-x","article-title":"Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat","volume":"26","author":"Hara","year":"2008","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.lfs.2020.117443_bb0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.RES.83.5.508","article-title":"Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes","volume":"83","author":"Nishi","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0225","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1073\/pnas.91.3.1069","article-title":"Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes","volume":"91","author":"Nakano","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.117443_bb0230","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.80.5.638","article-title":"Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes","volume":"80","author":"Nishi","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0235","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbrc.2011.10.119","article-title":"Lysophosphatidylcholine enhances the suppressive function of human naturally occurring regulatory T cells through TGF-beta production","volume":"415","author":"Hasegawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117443_bb0240","doi-asserted-by":"crossref","unstructured":"Piccirillo, A.R.; Hyzny, E.J.; Beppu, L.Y.; Menk, A.V.; Wallace, C.T.; Hawse, W.F.; Buechel, H.M.; Wong, B.H.; Foo, J.C.; Cazenave-Gassiot, A., et al. The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8(+) Memory T Cell Maintenance and Secondary Response to Infection. J Immunol 2019, 203, 117\u2013126, doi:https:\/\/doi.org\/10.4049\/jimmunol.1801585.","DOI":"10.4049\/jimmunol.1801585"},{"key":"10.1016\/j.lfs.2020.117443_bb0245","doi-asserted-by":"crossref","unstructured":"Hong, C.W.; Kim, T.K.; Ham, H.Y.; Nam, J.S.; Kim, Y.H.; Zheng, H.; Pang, B.; Min, T.K.; Jung, J.S.; Lee, S.N., et al. Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine.GlyR alpha 2\/TRPM2\/p38 MAPK signaling. J Immunol 2010, 184, 4401\u20134413, doi:https:\/\/doi.org\/10.4049\/jimmunol.0902814.","DOI":"10.4049\/jimmunol.0902814"},{"key":"10.1016\/j.lfs.2020.117443_bb0250","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1189\/jlb.0507292","article-title":"Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils","volume":"82","author":"Ojala","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0255","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2008-04-149831","article-title":"Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer","volume":"112","author":"Chang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.117443_bb0260","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/toxins6092840","article-title":"Oxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytes","volume":"6","author":"Rolin","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.lfs.2020.117443_bb0265","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/ATVBAHA.109.191585","article-title":"Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration","volume":"29","author":"Tan","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0270","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.RES.87.1.52","article-title":"Lysophosphatidylcholine activates p38 and p42\/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis","volume":"87","author":"Jing","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0275","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood-2004-05-1916","article-title":"Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.117443_bb0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jcp.21857","article-title":"Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration","volume":"221","author":"Schilling","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.117443_bb0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00424-009-0710-y","article-title":"Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity","volume":"459","author":"Schilling","year":"2009","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.lfs.2020.117443_bb0290","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.intimp.2016.07.014","article-title":"Stearoyl lysophosphatidylcholine enhances the phagocytic ability of macrophages through the AMP-activated protein kinase\/p38 mitogen activated protein kinase pathway","volume":"39","author":"Quan","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cellimm.2014.04.010","article-title":"Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation","volume":"289","author":"Qin","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0300","first-page":"246","article-title":"Schistosomal-derived lysophosphatidylcholine triggers M2 polarization of macrophages through PPARgamma dependent mechanisms","volume":"2017","author":"Assuncao","year":"1862","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2020.117443_bb0305","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/hc0802.104457","article-title":"HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells","volume":"105","author":"Yokoyama","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.117443_bb0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5483\/BMBRep.2017.50.6.182","article-title":"Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cells","volume":"50","author":"Jung","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.lfs.2020.117443_bb0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4196\/kjpp.2009.13.1.27","article-title":"Oxidized low-density lipoprotein- and lysophosphatidylcholine-induced Ca mobilization in human endothelial cells","volume":"13","author":"Kim","year":"2009","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.lfs.2020.117443_bb0320","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.RES.78.5.780","article-title":"Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors","volume":"78","author":"Murohara","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0325","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.RES.74.4.565","article-title":"Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C","volume":"74","author":"Sugiyama","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0330","doi-asserted-by":"crossref","unstructured":"Takabe, W.; Kanai, Y.; Chairoungdua, A.; Shibata, N.; Toi, S.; Kobayashi, M.; Kodama, T.; Noguchi, N. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2. Arterioscler Thromb Vasc Biol 2004, 24, 1640\u20131645, doi:https:\/\/doi.org\/10.1161\/01.ATV.0000134377.17680.26.","DOI":"10.1161\/01.ATV.0000134377.17680.26"},{"key":"10.1016\/j.lfs.2020.117443_bb0335","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/jcmm.12903","article-title":"Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-kappaB pathway and SUMOylation","volume":"20","author":"Bi","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/iub.1458","article-title":"TSG attenuates LPC-induced endothelial cells inflammatory damage through notch signaling inhibition","volume":"68","author":"Zhao","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.lfs.2020.117443_bb0345","doi-asserted-by":"crossref","first-page":"106177","DOI":"10.18632\/oncotarget.22425","article-title":"Lysophosphatidylcholine induces cytotoxicity\/apoptosis and IL-8 production of human endothelial cells: related mechanisms","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.117443_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2008.01.029","article-title":"Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH\/ADMA\/NOS\/NO pathway in endothelial cells induced by lysophosphatidylcholine","volume":"584","author":"Feng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2016.11.022","article-title":"Role of ERK1\/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine","volume":"258","author":"Campos-Mota","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113443","article-title":"Oleoyl-lysophosphatidylcholine limits endothelial nitric oxide bioavailability by induction of reactive oxygen species","volume":"9","author":"Kozina","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117443_bb0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1139\/y11-021","article-title":"Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway","volume":"89","author":"Peng","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0370","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1582-4934.2008.00394.x","article-title":"Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway","volume":"13","author":"Xing","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0375","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/14767050802556075","article-title":"Lysophosphatidylcholine induces endothelial cell injury by nitric oxide production through oxidative stress","volume":"22","author":"Kim","year":"2009","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0380","first-page":"375","article-title":"Superoxide is a potential culprit of caspase-3 dependent endothelial cell death induced by lysophosphatidylcholine","volume":"61","author":"Park","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/fcp.12399","article-title":"Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells","volume":"33","author":"Tsai","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lfs.2020.117443_bb0390","doi-asserted-by":"crossref","unstructured":"Zhao, J.; Xu, S.; Song, F.; Nian, L.; Zhou, X.; Wang, S. 2,3,5,4\u2032-tetrahydroxystilbene-2-O-beta-D-glucoside protects human umbilical vein endothelial cells against lysophosphatidylcholine-induced apoptosis by upregulating superoxide dismutase and glutathione peroxidase. IUBMB Life 2014, 66, 711\u2013722, doi:https:\/\/doi.org\/10.1002\/iub.1321.","DOI":"10.1002\/iub.1321"},{"key":"10.1016\/j.lfs.2020.117443_bb0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00380-014-0473-z","article-title":"Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease","volume":"30","author":"Hong","year":"2015","journal-title":"Heart Vessel."},{"key":"10.1016\/j.lfs.2020.117443_bb0400","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.105.021667","article-title":"RanGAP-mediated nuclear protein import in vascular smooth muscle cells is augmented by lysophosphatidylcholine","volume":"71","author":"Faustino","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0405","first-page":"503","article-title":"The atherogenic actions of LPC on vascular smooth muscle cells and its LPA receptor mediated mechanism","volume":"2018","author":"Bao","year":"1911","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117443_bb0410","doi-asserted-by":"crossref","unstructured":"Toita, R.; Asai, D.; Otani, K.; Kawano, T.; Murata, M.; Kang, J.H. Suppression of Lysophosphatidylcholine-Induced Human Aortic Smooth Muscle Cell Calcification by Protein Kinase A Inhibition. Lipids 2019, https:\/\/doi.org\/10.1002\/lipd.12178.","DOI":"10.1002\/lipd.12178"},{"key":"10.1016\/j.lfs.2020.117443_bb0415","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3346\/jkms.2012.27.7.803","article-title":"Impact of lysophosphatidylcholine on the plasminogen activator system in cultured vascular smooth muscle cells","volume":"27","author":"Yoon","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0420","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jss.2017.02.028","article-title":"Lysophosphatidylcholine activates the Akt pathway to upregulate extracellular matrix protein production in human aortic valve cells","volume":"213","author":"Cheng","year":"2017","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0425","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13239-014-0197-3","article-title":"Differential aortic and mitral valve interstitial cell mineralization and the induction of mineralization by lysophosphatidylcholine in vitro","volume":"5","author":"Wiltz","year":"2014","journal-title":"Cardiovasc. Eng. Technol."},{"key":"10.1016\/j.lfs.2020.117443_bb0430","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bjp.0706937","article-title":"Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta","volume":"149","author":"Matsumoto","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0435","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.devcel.2016.06.018","article-title":"Microglia colonization of developing zebrafish midbrain is promoted by apoptotic neuron and lysophosphatidylcholine","volume":"38","author":"Xu","year":"2016","journal-title":"Dev. Cell"},{"key":"10.1016\/j.lfs.2020.117443_bb0440","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/glia.20815","article-title":"Lysophosphatidylcholine induces glial cell activation: role of rho kinase","volume":"57","author":"Sheikh","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2020.117443_bb0445","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.4049\/jimmunol.177.12.8560","article-title":"Lysophosphatidylcholine stimulates IL-1beta release from microglia via a P2X7 receptor-independent mechanism","volume":"177","author":"Stock","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0450","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2017.07.004","article-title":"Lysophosphatidylcholine activates caspase-1 in microglia via a novel pathway involving two inflammasomes","volume":"310","author":"Scholz","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/neup.12182","article-title":"Activated microglia in ischemic stroke penumbra upregulate MCP-1 and CCR2 expression in response to lysophosphatidylcholine derived from adjacent neurons and astrocytes","volume":"35","author":"Inose","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.lfs.2020.117443_bb0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cbf.1374","article-title":"Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE","volume":"25","author":"Hou","year":"2007","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.lfs.2020.117443_bb0465","first-page":"8","article-title":"Elevated serum lysophosphatidylcholine in patients with systemic lupus erythematosus impairs phagocytosis of necrotic cells in vitro","volume":"2017","author":"Grossmayer","year":"1876","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0470","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1194\/jlr.M900167-JLR200","article-title":"LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma","volume":"50","author":"Schaeffer","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0475","doi-asserted-by":"crossref","first-page":"532145","DOI":"10.1155\/2011\/532145","article-title":"LysoPC and PAF trigger arachidonic acid release by divergent signaling mechanisms in monocytes","volume":"2011","author":"Oestvang","year":"2011","journal-title":"J Lipids"},{"key":"10.1016\/j.lfs.2020.117443_bb0480","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2008.03.087","article-title":"Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages","volume":"370","author":"Olofsson","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.117443_bb0485","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4049\/jimmunol.169.4.1688","article-title":"Mature dendritic cell generation promoted by lysophosphatidylcholine","volume":"169","author":"Coutant","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0490","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jcp.22301","article-title":"Lysophosphatidylcholine-mediated functional inactivation of syndecan-4 results in decreased adhesion and motility of dendritic cells","volume":"225","author":"Buhligen","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2020.117443_bb0495","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","article-title":"Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis","volume":"28","author":"Paapstel","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2020.117443_bb0500","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Goncalves","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065155","article-title":"Acyl chain-dependent effect of lysophosphatidylcholine on endothelium-dependent vasorelaxation","volume":"8","author":"Rao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117443_bb0510","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000365037","article-title":"Rapid growth and childhood obesity are strongly associated with lysoPC(14:0)","volume":"64","author":"Rzehak","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.lfs.2020.117443_bb0515","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.atherosclerosis.2010.11.007","article-title":"Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells","volume":"214","author":"Riederer","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0520","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jb\/mvv044","article-title":"Lysophosphatidylcholine promotes SREBP-2 activation via rapid cholesterol efflux and SREBP-2-independent cytokine release in human endothelial cells","volume":"158","author":"Morita","year":"2015","journal-title":"J. Biochem."},{"key":"10.1016\/j.lfs.2020.117443_bb0525","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1194\/jlr.M006536","article-title":"Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production","volume":"51","author":"Riederer","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0530","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2017.12.002","article-title":"Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner","volume":"472","author":"Drzazga","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2020.117443_bb0535","doi-asserted-by":"crossref","first-page":"112598","DOI":"10.18632\/oncotarget.22607","article-title":"Reduced levels of N\u2019-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.117443_bb0540","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1128\/AAC.04986-14","article-title":"Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii","volume":"59","author":"Smani","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2020.117443_bb0545","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SHK.0000000000001012","article-title":"Stearoyl lysophosphatidylcholine inhibits endotoxin-induced caspase-11 activation","volume":"50","author":"Li","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2020.117443_bb0550","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/2211-5463.12152","article-title":"The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cells","volume":"6","author":"Ross","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.lfs.2020.117443_bb0555","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI117047","article-title":"Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells","volume":"93","author":"Kume","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.117443_bb0560","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.RES.77.3.530","article-title":"Elevated levels of cAMP inhibit protein kinase C--independent mechanisms of endothelial platelet-derived growth factor-B chain and intercellular adhesion molecule-1 gene induction by lysophosphatidylcholine","volume":"77","author":"Ochi","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0565","doi-asserted-by":"crossref","unstructured":"Lu, Y.; Sun, Y.; Drummer, C.t.; Nanayakkara, G.K.; Shao, Y.; Saaoud, F.; Johnson, C.; Zhang, R.; Yu, D.; Li, X., et al. Increased acetylation of H3K14 in the genomic regions that encode trained immunity enzymes in lysophosphatidylcholine-activated human aortic endothelial cells - Novel qualification markers for chronic disease risk factors and conditional DAMPs. Redox Biol 2019, 24, 101221, doi:https:\/\/doi.org\/10.1016\/j.redox.2019.101221.","DOI":"10.1016\/j.redox.2019.101221"},{"key":"10.1016\/j.lfs.2020.117443_bb0570","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3892\/ijmm.2012.1211","article-title":"Inhibitory effects of paeoniflorin on lysophosphatidylcholine-induced inflammatory factor production in human umbilical vein endothelial cells","volume":"31","author":"Li","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0575","first-page":"4011","article-title":"Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells","volume":"17","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2020.117443_bb0580","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/ATVBAHA.115.306964","article-title":"Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation","volume":"36","author":"Li","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0585","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI118211","article-title":"Wu, K.K. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine","volume":"96","author":"Zembowicz","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.117443_bb0590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4196\/kjpp.2008.12.1.31","article-title":"Lysophosphatidylcholine increases ca current via activation of protein kinase C in rabbit portal vein smooth muscle cells","volume":"12","author":"Jung","year":"2008","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.lfs.2020.117443_bb0595","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1600-079X.2001.300207.x","article-title":"Melatonin counteracts potentiation by lysophosphatidylcholine of serotonin-induced vasoconstriction in human umbilical artery: relation to calcium influx","volume":"30","author":"Okatani","year":"2001","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0600","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2011.04.022","article-title":"Labedipinedilol-a prevents lysophosphatidylcholine-induced vascular smooth muscle cell death through reducing reactive oxygen species production and anti-apoptosis","volume":"217","author":"Hsu","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2220\/biomedres.29.1","article-title":"Cyclooxygenase-2 induction by lysophosphatidylcholine in cultured rat vascular smooth muscle cells: involvement of the p38MAPK pathway","volume":"29","author":"Yamakawa","year":"2008","journal-title":"Biomed. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0610","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.103.10.1440","article-title":"Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation","volume":"103","author":"Watanabe","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.117443_bb0615","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.98.4.353","article-title":"Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration","volume":"98","author":"Kohno","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.117443_bb0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2013.08.001","article-title":"PKCvarepsilon mediates serine phosphorylation of connexin43 induced by lysophosphatidylcholine in neonatal rat cardiomyocytes","volume":"314","author":"Liao","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2020.117443_bb0625","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1074\/jbc.M116.721035","article-title":"Structural insights into the transport mechanism of the human sodium-dependent lysophosphatidylcholine transporter MFSD2A","volume":"291","author":"Quek","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.117443_bb0630","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.phrs.2015.12.024","article-title":"Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier","volume":"104","author":"Wang","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0635","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ng.3313","article-title":"A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome","volume":"47","author":"Alakbarzade","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2020.117443_bb0640","first-page":"658","article-title":"Lysophosphatidylcholine export by human ABCA7","volume":"2017","author":"Tomioka","year":"1862","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2020.117443_bb0645","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.dadm.2015.05.003","article-title":"The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer\u2019s disease and mild cognitive impairment","volume":"1","author":"Klavins","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.lfs.2020.117443_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11766-0","article-title":"Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice","volume":"7","author":"Sugasini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.117443_bb0655","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1194\/jlr.M090464","article-title":"Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: potential treatment for depression","volume":"60","author":"Yalagala","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0660","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jnr.21821","article-title":"Lysophosphatidylcholine protects cerebellar granule neurons from apoptotic cell death","volume":"87","author":"Ikeno","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0665","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fob.2013.05.003","article-title":"Lysophosphatidylcholine enhances NGF-induced MAPK and Akt signals through the extracellular domain of TrkA in PC12 cells","volume":"3","author":"Wuhanqimuge Itakura","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.lfs.2020.117443_bb0670","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1007\/s12035-015-9528-0","article-title":"Lysophosphatidylcholine drives neuroblast cell fate","volume":"53","author":"Paoletti","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2020.117443_bb0675","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/hmg\/ddm029","article-title":"Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration","volume":"16","author":"Zhang","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.lfs.2020.117443_bb0680","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2020.117443_bb0685","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2013.03.002","article-title":"Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus","volume":"106","author":"Wang","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2020.117443_bb0690","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1744-8069-6-78","article-title":"Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine","volume":"6","author":"Nagai","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2020.117443_bb0695","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/glia.20449","article-title":"T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS","volume":"55","author":"Ghasemlou","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2020.117443_bb0700","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.lfs.2020.117443_bb0705","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2015.02.034","article-title":"Lysophosphatidylcholine increases the neurotoxicity of Alzheimer's amyloid beta1-42 peptide: role of oligomer formation","volume":"292","author":"Sheikh","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2020.117443_bb0710","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/aps.2009.25","article-title":"Effects of lysophosphatidylcholine on beta-amyloid-induced neuronal apoptosis","volume":"30","author":"Qin","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2020.117443_bb0715","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5387\/fms.2015-23","article-title":"Differential effects of lysophosphatidylcholine and ACh on muscarinic K(+),non-selective cation and Ca(2+) currents in guinea-pig atrial cells","volume":"62","author":"Li","year":"2016","journal-title":"Fukushima J. Med. Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0720","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1038\/s41598-019-46185-w","article-title":"Activation of the phosphatidylcholine to lysophosphatidylcholine pathway is associated with osteoarthritis knee cartilage volume loss over time","volume":"9","author":"Zhai","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.117443_bb0725","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kew207","article-title":"Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis","volume":"55","author":"Zhang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lfs.2020.117443_bb0730","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.2337\/dc12-1760","article-title":"Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver","volume":"36","author":"Lehmann","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2020.117443_bb0735","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/toxsci\/kfu132","article-title":"Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis","volume":"141","author":"Saito","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2020.117443_bb0740","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prostaglandins.2016.06.001","article-title":"Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis","volume":"124","author":"Krautbauer","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.lfs.2020.117443_bb0745","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.1400699","article-title":"Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease","volume":"193","author":"Maricic","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0750","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2020.117443_bb0755","doi-asserted-by":"crossref","first-page":"G77","DOI":"10.1152\/ajpgi.00301.2011","article-title":"Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis","volume":"302","author":"Kakisaka","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2020.117443_bb0760","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4168\/aair.2014.6.1.61","article-title":"Bioactive lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of asthmatic subjects","volume":"6","author":"Yoder","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.lfs.2020.117443_bb0765","doi-asserted-by":"crossref","DOI":"10.1038\/srep27430","article-title":"Lysophosphatidylcholine plays critical role in allergic airway disease manifestation","volume":"6","author":"Bansal","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.117443_bb0770","doi-asserted-by":"crossref","unstructured":"Zhuge, Y.; Yuan, Y.; van Breemen, R.; Degrand, M.; Holian, O.; Yoder, M.; Lum, H. Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1. Allergy Asthma Immunol Res 2014, 6, 66\u201374, doi:https:\/\/doi.org\/10.4168\/aair.2014.6.1.66.","DOI":"10.4168\/aair.2014.6.1.66"},{"key":"10.1016\/j.lfs.2020.117443_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041456","article-title":"Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes","volume":"7","author":"Barber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117443_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111348","article-title":"Alterations of plasma lysophosphatidylcholine species in obesity and weight loss","volume":"9","author":"Heimerl","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117443_bb0785","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/SHK.0b013e3181cb9266","article-title":"A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury","volume":"33","author":"Dial","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2020.117443_bb0790","doi-asserted-by":"crossref","unstructured":"Park, D.W.; Kwak, D.S.; Park, Y.Y.; Chang, Y.; Huh, J.W.; Lim, C.M.; Koh, Y.; Song, D.K.; Hong, S.B. Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. J Crit Care 2014, 29, 882 e885\u2013811, doi:https:\/\/doi.org\/10.1016\/j.jcrc.2014.05.003.","DOI":"10.1016\/j.jcrc.2014.05.003"},{"key":"10.1016\/j.lfs.2020.117443_bb0795","first-page":"89","article-title":"Antimicrobial effects of lysophosphatidylcholine on methicillin-resistant Staphylococcus aureus","volume":"4","author":"Miyazaki","year":"2017","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.lfs.2020.117443_bb0800","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/AAC.02708-15","article-title":"Efficacy of lysophosphatidylcholine in combination with antimicrobial agents against Acinetobacter baumannii in experimental murine peritoneal Sepsis and pneumonia models","volume":"60","author":"Parra Millan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2020.117443_bb0805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nm989","article-title":"Therapeutic effects of lysophosphatidylcholine in experimental sepsis","volume":"10","author":"Yan","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.117443_bb0810","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.10.001","article-title":"Anti-inflammatory action of arachidonoyl lysophosphatidylcholine or 15-hydroperoxy derivative in zymosan A-induced peritonitis","volume":"90","author":"Hung","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.lfs.2020.117443_bb0815","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10753-010-9218-z","article-title":"Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis","volume":"34","author":"Hung","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2020.117443_bb0820","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11745-010-3392-5","article-title":"Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory","volume":"45","author":"Huang","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.lfs.2020.117443_bb0825","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3389\/fimmu.2018.00920","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2020.117443_bb0830","doi-asserted-by":"crossref","unstructured":"Brancucci, N.M.B.; Gerdt, J.P.; Wang, C.; De Niz, M.; Philip, N.; Adapa, S.R.; Zhang, M.; Hitz, E.; Niederwieser, I.; Boltryk, S.D., et al. Lysophosphatidylcholine regulates sexual stage differentiation in the human Malaria parasite Plasmodium falciparum. Cell 2017, 171, 1532\u20131544 e1515, doi:https:\/\/doi.org\/10.1016\/j.cell.2017.10.020.","DOI":"10.1016\/j.cell.2017.10.020"},{"key":"10.1016\/j.lfs.2020.117443_bb0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2015.01.006","article-title":"Lysophosphatidylcholine exacerbates Leishmania major-dendritic cell infection through interleukin-10 and a burst in arginase1 and indoleamine 2,3-dioxygenase activities","volume":"25","author":"Tounsi","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2020.117443_bb0840","doi-asserted-by":"crossref","first-page":"625838","DOI":"10.1155\/2012\/625838","article-title":"Lysophosphatidylcholine: a novel modulator of Trypanosoma cruzi transmission","volume":"2012","author":"Silva-Neto","year":"2012","journal-title":"J Parasitol Res"},{"key":"10.1016\/j.lfs.2020.117443_bb0845","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1128\/IAI.00683-08","article-title":"Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine","volume":"76","author":"Mesquita","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2020.117443_bb0850","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.actatropica.2017.10.022","article-title":"Triatoma infestans relies on salivary lysophosphatidylcholine to enhance Trypanosoma cruzi transmission","volume":"178","author":"Lima","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.lfs.2020.117443_bb0855","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1134\/S1607672910040010","article-title":"Disorders of tissue transformations of lysophosphatidylcholines at experimental pancreatic diabetes in white rats and peculiarities of the corrective effect of low-energy laser radiation of an extremely low intensity","volume":"433","author":"Burlakova","year":"2010","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.lfs.2020.117443_bb0860","doi-asserted-by":"crossref","unstructured":"Zhang, S.Y.; Dong, Y.Q.; Wang, P.; Zhang, X.; Yan, Y.; Sun, L.; Liu, B.; Zhang, D.; Zhang, H.; Liu, H., et al. Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance. EBioMedicine 2018, 31, 202\u2013216, doi:https:\/\/doi.org\/10.1016\/j.ebiom.2018.04.022.","DOI":"10.1016\/j.ebiom.2018.04.022"},{"key":"10.1016\/j.lfs.2020.117443_bb0865","doi-asserted-by":"crossref","first-page":"E1276","DOI":"10.1152\/ajpendo.00475.2009","article-title":"A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice","volume":"297","author":"Cheng","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2020.117443_bb0870","doi-asserted-by":"crossref","unstructured":"Diamanti, K.; Cavalli, M.; Pan, G.; Pereira, M.J.; Kumar, C.; Skrtic, S.; Grabherr, M.; Riserus, U.; Eriksson, J.W.; Komorowski, J., et al. Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes. Sci Rep 2019, 9, 9653, doi:https:\/\/doi.org\/10.1038\/s41598-019-45906-5.","DOI":"10.1038\/s41598-019-45906-5"},{"key":"10.1016\/j.lfs.2020.117443_bb0875","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2016.05.004","article-title":"Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients","volume":"251","author":"Menegaut","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2020.117443_bb0880","doi-asserted-by":"crossref","unstructured":"Drzazga, A.; Sowinska, A.; Krzeminska, A.; Okruszek, A.; Paneth, P.; Koziolkiewicz, M.; Gendaszewska-Darmach, E. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from betaTC-3 pancreatic cells: Evaluation of structure-dependent biological activity. Biochim Biophys Acta Mol Cell Biol Lipids 2018, 1863, 91\u2013103, doi:https:\/\/doi.org\/10.1016\/j.bbalip.2017.10.004.","DOI":"10.1016\/j.bbalip.2017.10.004"},{"key":"10.1016\/j.lfs.2020.117443_bb0885","doi-asserted-by":"crossref","first-page":"33833","DOI":"10.1074\/jbc.M109.024869","article-title":"Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes","volume":"284","author":"Yea","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.117443_bb0890","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1165\/rcmb.2014-0379RC","article-title":"Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis","volume":"53","author":"Priolo","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.117443_bb0895","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jhbp.256","article-title":"Cholangiocyte senescence caused by lysophosphatidylcholine as a potential implication in carcinogenesis","volume":"22","author":"Shimizu","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.lfs.2020.117443_bb0900","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00595-018-1675-2","article-title":"Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery","volume":"48","author":"Matsuda","year":"2018","journal-title":"Surg. Today"},{"key":"10.1016\/j.lfs.2020.117443_bb0905","doi-asserted-by":"crossref","unstructured":"Goto, T.; Terada, N.; Inoue, T.; Kobayashi, T.; Nakayama, K.; Okada, Y.; Yoshikawa, T.; Miyazaki, Y.; Uegaki, M.; Utsunomiya, N., et al. Decreased expression of lysophosphatidylcholine (16:0\/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer. Prostate 2015, 75, 1821\u20131830, doi:https:\/\/doi.org\/10.1002\/pros.23088.","DOI":"10.1002\/pros.23088"},{"key":"10.1016\/j.lfs.2020.117443_bb0910","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1535-7163.MCT-10-0474","article-title":"Lysophosphatidylcholine pretreatment reduces VLA-4 and P-selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo","volume":"10","author":"Jantscheff","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2020.117443_bb0915","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12944-015-0070-x","article-title":"Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases","volume":"14","author":"Raynor","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2020.117443_bb0920","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mc.20524","article-title":"Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells","volume":"48","author":"Gaetano","year":"2009","journal-title":"Mol. Carcinog."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520301910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:32:47Z","timestamp":1758400367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520301910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":184,"alternative-id":["S0024320520301910"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117443","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanisms of lysophosphatidylcholine in the development of diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117443"}}